Legal status · Australia
Is ATX-304 legal in Australia?
No. ATX-304 is not an approved medicine in Australia; its classification is "Not approved; Schedule 4 or import-restricted". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. Human evidence: Preliminary.
ATX-304 in Australia at a glance
| Classification | Not approved; Schedule 4 or import-restricted |
|---|---|
| TGA approval status | Not approved by TGA |
| Evidence level | Preliminary (research strength: Preliminary) |
| Reviewed | Sep 2026 |
Classification and note come from the ATX-304 profile, checked against Therapeutic Goods Administration (TGA) listings at the reviewed date.
What this means
- 01
No product containing ATX-304 is approved by TGA for any use in Australia, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in Australia. This page is general information, not legal advice.
What ATX-304 is
An oral AMPK activator with one 28-day human pilot in type 2 diabetes and recent mouse data, now sold as a research chemical and promoted as an exercise mimetic or metformin replacement.
ATX-304 keeps AMPK switched on by blocking its dephosphorylation rather than by draining cellular energy. A 28-day Phase 2a in people with type 2 diabetes already on metformin improved glucose handling and microvascular blood flow, and 2025 mouse work showed benefits in fatty liver and oxidative stress.
Mechanism: Pan-AMPK activation via inhibition of PP2C-mediated dephosphorylation at Thr172, with mild mitochondrial uncoupling.
Regulatory history: Investigational history; sold as an unapproved research chemical
How TGA treats this kind of product
Registers or lists therapeutic goods on the ARTG and schedules substances in the Poisons Standard. Many peptides are Schedule 4 (prescription only), so possession without a prescription and personal importation are restricted even when no product is registered.
The classification above is the The Longevity Archive reading of Therapeutic Goods Administration listings for ATX-304 at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
ATX-304 in other countries
Frequently asked questions
Is ATX-304 legal in Australia?
No. ATX-304 is not an approved medicine in Australia; its classification is "Not approved; Schedule 4 or import-restricted". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. Human evidence: Preliminary.
Can I buy ATX-304 in Australia?
No approved product exists to buy. In Australia ATX-304 is classified as "Not approved; Schedule 4 or import-restricted", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.
Is ATX-304 TGA approved?
No. In Australia ATX-304 is classified as "Not approved; Schedule 4 or import-restricted", which is not a TGA marketing approval. For comparison, the US FDA status is: Investigational history; sold as an unapproved research chemical. Evidence level: Preliminary.
Related compounds in Australia
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for ATX-304 live on its compound profile.
ATX-304 profileThis page is general information about the regulatory status of ATX-304 in Australia, current as of Sep 2026. It is not legal advice, and classifications change; check Therapeutic Goods Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.